TcrossGlobal

Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial

The REC-CAGEFREE I trial demonstrated that among patients with de novo coronary artery disease, treatment with a paclitaxel-coated balloon (DCB) plus provisional rescue stenting was associated with a higher risk of 3-year device-oriented composite events (DOCE) compared with planned drug-eluting stent (DES) implantation, Dr. Ling Tao and colleagues, Xijing Hospital, China, reported in the January 27 issue of the Journal of the American College of Cardiology.

The researchers evaluated 2,272 patients with de novo coronary lesions who underwent successful pred...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.